Kevin Flyangolts

Kevin is founder and CEO of Aclid, a security and safety platform for biotechs. Aclid's platform helps biotechs comply with trade controls, international biosecurity and biosafety regulations, and federal funding requirements. The company works with DNA and RNA manufacturers in biosecurity, life sciences research labs in biosafety, and with US defense in biosurveillance.

Conference Pass

2,495

USD

Keynotes & Firesides

Workshops & Breakouts

1:1 Partnering App

Meals & Receptions

Session Recordings

Until Friday April 25th

Full Rate:

$3,495

Other Speakers

Copyright SynBioBeta 2025